Research Article
Volume 9 Issue 7 - 2020
Should Women Opt for “Natural” or “Artificial” Family Planning and Birth Control
Kurt Kraetschmer*
Austrian American Medical Research Institute, Wiener Neustadt, Austria
*Corresponding Author: Kurt Kraetschmer, Austrian American Medical Research Institute, Wiener Neustadt, Austria
Received: February 08, 2020; Published: June 26, 2020


Background: For many years now, the importance of family planning has been elucidated from a medical as well as economic perspective. The latter highlights the advantages for the taxpayer, the former investigates whether the benefits of contraception outweigh in fact the risks of a pregnancy. Women who are persuaded by the arguments that unintended pregnancy and abortion should be averted have to make difficult decisions regarding suitable methods for family planning and birth control.

Aim: The aim of the present study is to assist women in their decision-making process regarding the personally most suitable method of family planning and birth control. In pursing this aim it analyses the most important presently available methods by underscoring safety. To clarify the concept “safety” for family planning and birth control it draws attention to adverse events, risks, and potential complications. The emphasis on safety aims at enabling women to assess each possible method critically in accord with principles of personalized medicine.

Material and Method: The method consists in an analysis of the various contraceptive possibilities with respect to safety and efficacy. This analysis is guided by the principles of “nil nocere” (no harm) and “informed consent”. The former emphasizes safety, the second completeness of information for each woman. The material analysed comprises publications gathered from the most influential and authoritative sources, i.e. WHO, U.S. FDA, U.S. CDC, Planned Parenthood, the most renowned international research institutes and top-ranked scientific journals.

Results: Women who prioritize safety in their contraceptive pursuits are advised to engage in natural methods of family planning which have to implemented with strict compliance in order to achieve perfect use estimates. Women who value efficacy more than safety are advised to carefully consider adverse events, risks and potential complications. In these considerations they should avail themselves of reliable sources of information and avoid unreliable sources, such as those proposed by the U.S. Food and Drug Administration (FDA), the U.S. CDC, Planned Parenthood, misleading social media, and publications by authors declaring conflicts of interest. In their search for trustworthy information, they should consult such sources as Contraceptive Technology, evidence-based publications by the World Health Organization (WHO), the “Safety-based Summary of Contraception/Synoptic Overview of Contraceptive Methods” of 2020 (contained in this article) and ongoing research in pharmacovigilance and pharmaceuticovigilance.

Keywords: Family Planning; Birth Control; Decision-Making Process


  1. Cleland K., et al. “Family planning as a cost-saving preventive health service”. The New England Journal of Medicine 364 (2011): e37.
  2. Curtis KM and Peipert JF. “Long-Acting Reversible Contraception”. The New England Journal of Medicine 376 (2017): 461-468.
  3. Jones J., et al. “Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995”. National Health Statistics Reports; no 60. Hyattsville, MD: National Center for Health Statistics (2012).
  4. Gröger S., et al. “Gynäkologie und Geburtshilfe”. In: K. Diedrich (Ed.) Berlin: Springer (2000): 60-87.
  5. Trussell J. “Contraceptive efficacy. Table 3-2”. In: Hatcher RA., et al. Contraceptive Technology: 20th Revised Edition. New York, NY: Ardent Media (2011).
  6. World Health Organization (WHO).
  7. WHO (2020).
  8. Food and Drug Administration (FDA) Approved Methods of Birth Control (2013).
  9. Food and Drug Administration. FDA’s Birth Control Chart of 2018 (2018).
  10. “Effectiveness of Family Planning Methods of 2016”. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use (2016).
  11. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use (2017).
  12. Kraetschmer K. “Safety of contraception challenged by recent adverse events and threats to women’s health”. Journal of Basic and Clinical Reproductive Sciences 8 (2019): 1-3.
  13. Kraetschmer K. “Is Contraception Really Safe?” International journal of Sexual Health and Reproductive Health 1 (2019): 1-11.
  14. Kraetschmer K. “Safety of Birth Control and Contraception: Pharmaceutical Companies on the Testing Bench”. LOJ Phar and Climate Resilient 4 (2019).
  15. Kraetschmer K. “Topical Issues in Translational Pharmacology and Pharmaceuticovigilance: Can Pharmacological Research on Birth Control and Contraception Meet the Requirements of Bioethical Standards?” Journal of Pharmaceutical Sciences and Pharmacology (2019): 87-104.
  16. Kraetschmer K. “Birth Control and Contraception: The Dilemma of Informed Consent”. Perceptions in Reproductive Medicine 4 (2018): 163-166.
  17. Washington Post (2018).
  18. The Guardian. 01.40 BST Last modified on Mon 02.55 BST (2018).
  19. American Congress of Obstetricians and Gynecologists (2017).
  20. Liao C., et al. “Reclaiming fertility awareness methods to inform timed intercourse for HIV serodiscordant couples attempting to conceive”. Journal of the International AIDS Society 18 (2015): 19447.
  21. Kraetschmer K. “Are women denied the right of self-decision in matters of birth control and contraception”. Saarbrücken: Scholars’ Press (2017).
  22. Code of Medical Ethics. Current Opinions American Medical Association. Chicago, Illinois. 23 Planned Parenthood. Comparing Typical Effectiveness of Contraceptive Methods (1992).
  23. Beers MH, Berkow R. “MSD Manual”. Whitehouse Station, N.J. USA: Merck and Co. Inc. (17th edition) (1999).
  24. Georgetown University (2017).
  25. Planned Parenthood. Fertility-Awareness.
  26. World Health Organisation. Birth Control.
  27. Wildemeersch D., et al. “The frameless intrauterine contraceptive implant -- an update for interval, emergency and postabortal contraception”. The British Journal of Family Planning 4 (1999): 149-159.
  28. CONTREL- GyneFix. Information for the user. CONTREL Manufacturer. CONTREL EUROPE nv Incubatie - en innovatiecentrum. Technologiepark 3 B1 (Universiteit Gent), 9052 Gent (Zwijnaarde).
  29. Hargreave M., et al. “Maternal use of hormonal contraception and risk of childhood leukaemia – Authors' reply”. Maternal use of hormonal contraception and risk of childhood leukaemia”. The Lancet Oncology Correspondence12 (2018): 659.
  30. European Medicines Agency. Science Medicines Health. EMA/PRAC/689235/2018. Pharmacovigilance Risk Assessment Committee (PRAC) (2018).
  31. Bhanwra S and Ahluwalia K. “The association of oral contraceptive pills with increase in intraocular pressure: Time for pharmacovigilance to step in”. Journal of Pharmacology and Pharmacotherapeutics1 (2015): 51.
  32. Zethraeus N., et al. “A first choice combined oral contraceptive influences general well-being in healthy women”. Fertility and Sterility (2017).
  33. Birth Control Pills Still Linked to Breast Cancer, Study Finds. By Roni Caryn Rabin. New York Times (2017)..
  34. Essure permanent birth control. 2002 Bayer. Rights Reserved. Printed in USA (2017).
  35. News Release. ESSURE safe-efficacy News release. 2018 Bayer. Bayer and the Bayer Cross are registered trademarks of Bayer (2018).
  36. Essure.
  37. Kraetschmer K. “Can emergency contraception play a pivotal role in preventing unintended pregnancy and abortion”. Journal of Gynecology and Infertility1 (2018): 1-11.
  38. Trussell J., et al. “Emergency Contraception: A Last Chance to Prevent Unintended Pregnancy”. Office of Population Research, Princeton University, Princeton NJ 08544, USA (2017).
  39. Mirena (levonorgestrel-releasing intrauterine system). Bayer HealthCare Pharmaceuticals Inc. Wayne, NJ 07470. All rights reserved. component codes. Bayer Information. Patient information booklet (2008).
  40. Mayo Clinic (2020).
  41.–manufacturer. Manufactured by Veru Inc. Miami, FL 33137, USA.
  42. Food and Drug Administration. FC2 (2020).
  43. Summary of Safety and Effectiveness Data (SSED). In: FDA Medical Bulletin: Important Information for Health Professionals from the U.S. Food and Drug Administration 23.2 (1993): 4.
  44. Morelli I., et al. Wie Hormone krank machen. Regenerieren und hormonfrei verhüten. Blog Generation-Pille (2018).
Citation: Kurt Kraetschmer. “Should Women Opt for “Natural” or “Artificial” Family Planning and Birth Control”. EC Gynaecology 9.7 (2020): 09-21.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before August 18, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.